Comparative cost-effectiveness of cabozantinib as second-line therapy for patients with advanced hepatocellular carcinoma in Germany and the United States

by Maximilian Sieg, Michael Hartmann, Utz Settmacher, Habibollah Arefian
Published 2020-04-01

Economic Evaluation of Interventions for Prevention of Hospital Acquired Infections: A Systematic Review.

by Habibollah Arefian, Monique Vogel, Anja Kwetkat, Michael Hartmann
Published 2016-01-01

Cost-effectiveness of allergic rhinitis treatment: An exploratory study

by Jan Titulaer, Habibollah Arefian, Michael Hartmann, Mustafa Z Younis, Orlando Guntinas-Lichius
Published 2018-08-01

Estimating extra length of stay due to healthcare-associated infections before and after implementation of a hospital-wide infection control program.

by Habibollah Arefian, Stefan Hagel, Dagmar Fischer, André Scherag, Frank Martin Brunkhorst, Jens Maschmann, Michael Hartmann
Published 2019-01-01